News
-
Datametrex Announces Transition to Semi-Annual Financial Reporting
-
AI/ML Innovations Inc. Closes First Tranche of Private Placement
-
Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement
-
Announces Private Placement of Convertible Promissory Notes
-
RUM Reports Quarterly Financial Results for June 30, 2026
-
Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
-
AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
-
MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
-
Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
-
MHM Corporate: reduces the nominal value of its shares to €0.011
-
Altareit: Altarea press release regarding the Primonial matter
-
Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
-
First half 2026 results
-
CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
-
Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026